We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Examining Effects of Domain Specific Episodic Future Thinking on Cannabis Use

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05324813
Recruitment Status : Recruiting
First Posted : April 12, 2022
Last Update Posted : April 12, 2022
Sponsor:
Collaborator:
Dartmouth College
Information provided by (Responsible Party):
Michael Sofis, Advocates for Human Potential

Tracking Information
First Submitted Date  ICMJE March 16, 2022
First Posted Date  ICMJE April 12, 2022
Last Update Posted Date April 12, 2022
Estimated Study Start Date  ICMJE April 2022
Estimated Primary Completion Date July 2022   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: April 10, 2022)
  • Number of cannabis use grams [ Time Frame: 1-week follow-up ]
  • Number of cannabis use days [ Time Frame: 1-week follow-up ]
Original Primary Outcome Measures  ICMJE Same as current
Change History No Changes Posted
Current Secondary Outcome Measures  ICMJE
 (submitted: April 10, 2022)
  • Number of tobacco use days [ Time Frame: 1-week follow-up ]
  • Number of alcohol use days [ Time Frame: 1-week follow-up ]
  • Number of tobacco use times [ Time Frame: 1-week follow-up ]
  • Number of alcoholic drinks [ Time Frame: 1-week follow-up ]
  • Rate of delay discounting [ Time Frame: 1-week follow-up ]
    5-trial adjusting delay discounting task
Original Secondary Outcome Measures  ICMJE Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Examining Effects of Domain Specific Episodic Future Thinking on Cannabis Use
Official Title  ICMJE Examining Effects of Domain Specific Episodic Future Thinking on Cannabis Use
Brief Summary The overarching goal of this online study is to compare the efficacy of six (weekly) sessions of Domain-Specific Episodic Future Thinking (DS-EFT) relative an active control condition on improving the ability to value future rewards and reducing cannabis use (grams and days of use), tobacco use, and alcohol use among.
Detailed Description Not Provided
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Condition  ICMJE
  • Marijuana Use
  • Marijuana Dependence
  • Tobacco Use
  • Alcohol Use, Unspecified
Intervention  ICMJE Behavioral: Domain-Specific Episodic Future Thinking
Individualized intervention that provides systematic prompts to enable creation and envisioning of positive future events across multiple life domains.
Study Arms  ICMJE
  • Experimental: Domain-Specific Episodic Future Thinking
    Intervention: Behavioral: Domain-Specific Episodic Future Thinking
  • Active Comparator: Episodic Recent Thinking Control Condition
    Intervention: Behavioral: Domain-Specific Episodic Future Thinking
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Recruiting
Estimated Enrollment  ICMJE
 (submitted: April 10, 2022)		 50
Original Estimated Enrollment  ICMJE Same as current
Estimated Study Completion Date  ICMJE July 2022
Estimated Primary Completion Date July 2022   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • at least 18 or older
  • reside in the U.S.
  • report wanting to reduce cannabis use (4 or higher on scale of 1-10 with higher scores indicating greater desire to reduce use)
  • report using cannabis at least 10 days in the last month
  • report using cannabis at least 100 days in their lifetime
  • Data quality checks passed

Exclusion Criteria:

-
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE
Contact: Michael J Sofis, PhD 14128678991 msofis@ahpnet.com
Listed Location Countries  ICMJE United States
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT05324813
Other Study ID Numbers  ICMJE 7420
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE
Plan to Share IPD: Yes
Supporting Materials: Study Protocol
Current Responsible Party Michael Sofis, Advocates for Human Potential
Original Responsible Party Same as current
Current Study Sponsor  ICMJE Michael Sofis
Original Study Sponsor  ICMJE Same as current
Collaborators  ICMJE Dartmouth College
Investigators  ICMJE
Principal Investigator: Michael J Sofis, PhD AHP
PRS Account Advocates for Human Potential
Verification Date April 2022

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP